Jul 31, 2024 / 08:00AM GMT
Javier Lopez-Belmonte Encina - Laboratorios Farmaceuticos ROVI SA - Chief Financial Officer
Good morning to everybody. A warm welcome to all those attending the presentation of ROVI's first half 2024 financial results, which will start in a moment. I'm Javier Lopez-Belmonte, ROVI's Deputy Chairman and Chief Financial Officer. Joining me on today's call are Juan Belmonte, ROVI's Chairman and CEO. The presentation will be followed by a Q&A session. (Event Instructions)
Before we begin, let me remind you that the information presented in this call contains forward-looking statements based on our current beliefs and expectations. Actual results could materially differ due to the known and unknown risks, uncertainties, and other factors, and we undertake no obligation to update or revise any of these statements.
With that, I thank you again for your presence here today. And I will now hand the presentation over to Juan Lopez-Belmonte. Please, Juan, go ahead.
Juan Lopez-Belmonte Encina - Laboratorios Farmaceuticos ROVI SA -
Q2 2024 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript
Jul 31, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers